relief-pe

Generic: acetaminophen, phenylephrine, chlorpheniramine

Labeler: hart health
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name relief-pe
Generic Name acetaminophen, phenylephrine, chlorpheniramine
Labeler hart health
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

acetaminophen 325 mg/1, chlorpheniramine maleate 2 mg/1, phenylephrine hydrochloride 5 mg/1

Manufacturer
HART Health

Identifiers & Regulatory

Product NDC 50332-0153
Product ID 50332-0153_129bfe8e-117e-4a42-98eb-e25990b3f2a5
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M
Listing Expiration 2027-12-31
Marketing Start 2012-04-16

Pharmacologic Class

Classes
adrenergic alpha1-agonists [moa] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] alpha-1 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 503320153
Hyphenated Format 50332-0153

Supplemental Identifiers

RxCUI
1046781
UNII
362O9ITL9D V1Q0O9OJ9Z 04JA59TNSJ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name relief-pe (source: ndc)
Generic Name acetaminophen, phenylephrine, chlorpheniramine (source: ndc)
Application Number M (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
  • 2 mg/1
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4)
  • 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7)
source: ndc

Packages (2)

50332-0153-4 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4) 50332-0153-7 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7)

Ingredients (3)

acetaminophen (325 mg/1) chlorpheniramine maleate (2 mg/1) phenylephrine hydrochloride (5 mg/1)

Linked Drug Pages (1)

Relief-PE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "129bfe8e-117e-4a42-98eb-e25990b3f2a5", "openfda": {"unii": ["362O9ITL9D", "V1Q0O9OJ9Z", "04JA59TNSJ"], "rxcui": ["1046781"], "spl_set_id": ["9475fb51-931b-4a89-be6b-62e715d0883e"], "manufacturer_name": ["HART Health"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4)", "package_ndc": "50332-0153-4", "marketing_start_date": "20120416"}, {"sample": false, "description": "250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7)", "package_ndc": "50332-0153-7", "marketing_start_date": "20120416"}], "brand_name": "Relief-PE", "product_id": "50332-0153_129bfe8e-117e-4a42-98eb-e25990b3f2a5", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "50332-0153", "generic_name": "ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE", "labeler_name": "HART Health", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Relief-PE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "CHLORPHENIRAMINE MALEATE", "strength": "2 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20120416", "listing_expiration_date": "20271231"}